cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Angion Biomedica Corp
15 own
11 watching
Current Price
$0.98
$-0.01
(-1.01%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
29.51M
52-Week High
52-Week High
2.04
52-Week Low
52-Week Low
0.46
Average Volume
Average Volume
0.31M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization29.51M
icon52-Week High2.04
icon52-Week Low0.46
iconAverage Volume0.31M
iconDividend Yield--
iconP/E Ratio--
What does the Angion Biomedica Corp do?
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company s lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.
Read More
How much money does Angion Biomedica Corp make?
News & Events about Angion Biomedica Corp.
PR Newswire
1month ago
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INFI, ANGN, NUVA, SUMO SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INFI, ANGN, NUVA, SUMO PR Newswire NEW YORK, April 17, 2023 NEW YORK, April 17, 2023 /PRNewswire/ --Halper Sadeh LLC, an investor rights law firm, is investigating the...
Globe Newswire
1month ago
NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: (NASDAQ: FRBA)s merger with Malvern Bancorp, ...
PR Newswire
1month ago
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CSII, ANGN, OSH, NUVA SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CSII, ANGN, OSH, NUVA PR Newswire NEW YORK, April 11, 2023 NEW YORK, April 11, 2023 /PRNewswire/ --Halper Sadeh LLC, an investor rights law firm, is investigating the following...
PR Newswire
1month ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, ANGN, TIG SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, ANGN, TIG PR Newswire NEW YORK, April 6, 2023 NEW YORK, April 6, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following...
Globe Newswire
2 months ago
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc. (NASDAQ: CSII)s ...
Frequently Asked Questions
Frequently Asked Questions
What is Angion Biomedica Corp share price today?
plus_minus_icon
Can Indians buy Angion Biomedica Corp shares?
plus_minus_icon
How can I buy Angion Biomedica Corp shares from India?
plus_minus_icon
Can Fractional shares of Angion Biomedica Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Angion Biomedica Corp stocks?
plus_minus_icon
What is today’s traded volume of Angion Biomedica Corp?
plus_minus_icon
What is today’s market capitalisation of Angion Biomedica Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Angion Biomedica Corp?
plus_minus_icon
What percentage is Angion Biomedica Corp down from its 52-Week High?
plus_minus_icon
What percentage is Angion Biomedica Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$0.98
$-0.01
(-1.01%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Applied Therapeutics Inc
Applied Therapeutics Inc
$1.29
$-0.01 (-0.77 %)
Magenta Therapeutics Inc
Magenta Therapeutics Inc
$0.65
$0.01 (2.26 %)
I-Mab
I-Mab
$3.10
$-0.08 (-2.52 %)
Immutep Ltd
Immutep Ltd
$2.01
$-0.12 (-5.63 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Applied Therapeutics Inc
Applied Therapeutics Inc
$1.29
$-0.01 (-0.77 %)
Magenta Therapeutics Inc
Magenta Therapeutics Inc
$0.65
$0.01 (2.26 %)
I-Mab
I-Mab
$3.10
$-0.08 (-2.52 %)
Immutep Ltd
Immutep Ltd
$2.01
$-0.12 (-5.63 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00